ASSOCIATION OF ADHESION MOLECULES WITH INTERSTITIAL LUNG DISEASE AND VASCULAR EVENTS INTWO RARE DISEASES: IDIOPATHIC INFLAMMATORY MYOPATHY AND SYSTEMIC SCLEROSIS!

被引：0
|
作者：
Colic, J. [1 ]
Notarnicola, A. [2 ]
Bukilica, M. Sefik [1 ,3 ]
Lundberg, I. E. [2 ]
Antovic, A. [2 ]
机构：
[1] Inst Rheumatol, Dept Rheumatol Unit, Belgrade, Serbia
[2] Karolinska Univ Hosp, Karolinska Inst, Dept Gastro Dermatol & Rheumatol, Stockholm, Sweden
[3] Univ Belgrade, Fac Med, Belgrade, Serbia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年 / 83卷
关键词：
Lungs; Biomarkers; Interdisciplinary research;
D O I：
10.1136/annrheumdis-2024-eular.5787
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1219
引用
收藏
页数：2
相关论文
共 50 条
  • [21] CYTOKINES IN SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS
    Zheng, B.
    Keen, K.
    Fritzler, M.
    Ryerson, C.
    Wilcox, P.
    Whalen, B.
    Sahin, B.
    Hou, H.
    Latham, P.
    Zhang, M. F.
    Yao, I.
    Dunne, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 729 - 729
  • [22] Increased circulating soluble vascular adhesion protein-1 levels in systemic sclerosis: association with lower frequency and severity of interstitial lung disease
    Yanaba, Koichi
    Yoshizaki, Ayumi
    Muroi, Eiji
    Ogawa, Fumihide
    Shimizu, Kazuhiro
    Sato, Shinichi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (04) : 442 - 447
  • [23] Expression of Inflammatory Markers in the Muscles of Patients with Idiopathic Inflammatory Myopathy According to the Presence of Interstitial Lung Disease
    Lee, Jung Sun
    Ghang, Byeongzu
    Choi, Wonho
    Hong, Seokchan
    Kim, Yong-Gil
    Lee, Chang-Keun
    Nam, Soo Jeong
    Yoo, Bin
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [24] Systemic Sclerosis Associated Interstitial Lung Disease and Nintedanib: A Rare Disease and a Promising Drug
    Kafle, Sunam
    Magar, Manusha Thapa
    Patel, Priyanka
    Poudel, Arisa
    Cancarevic, Ivan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [25] RARE CASE OF FULMINANT OF INTERSTITIAL LUNG DISEASE SECONDARY TO IDIOPATHIC INFLAMMATORY MYOSITIS
    Anwar, Raheel
    Medarov, Boris
    CHEST, 2022, 162 (04) : 2162A - 2162A
  • [26] Predictors of Interstitial Lung Disease (ILD) in patients with Idiopathic Inflammatory Myopathy-associated (IIM)
    Cocconcelli, E.
    Zanatta, E.
    Bellani, S.
    Castelli, G.
    Petrarulo, S.
    Iaccarino, L.
    Spagnolo, P.
    Balestro, E.
    Balestro, E.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [27] Efficacy and Safety of Nintedanib in Patients with Idiopathic Inflammatory Myopathy-related Interstitial Lung Disease
    Aoki, Kaito
    Shimura, Keigo
    Ohisa, Toshiki
    Ishii, Akira
    Sugiyama, Mai
    Ota, Yuichiro
    Nishikawa, Ayumi
    Sasaki, Noriko
    Yamada, Chiho
    Sato, Shinji
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 674 - 674
  • [28] Tacrolimus in idiopathic inflammatory myopathy-associated interstitial lung disease: defining roles and responders
    Gordon, Patrick
    Gooptu, Bibek
    RHEUMATOLOGY, 2015, 54 (01) : 3 - 4
  • [29] Comparison of nintedanib-induced gastrointestinal adverse events in patients with systemic sclerosis-associated interstitial lung disease and idiopathic interstitial pneumonias
    Imai, Miyu
    Okabayashi, Hiroko
    Akaike, Kimitaka
    Hamada, Shohei
    Masunaga, Aiko
    Ichiyasu, Hidenori
    Sakagami, Takuro
    RESPIROLOGY, 2023, 28 : 408 - 409
  • [30] Interstitial Lung Disease in Systemic Sclerosis: Lessons Learned from Idiopathic Pulmonary Fibrosis
    Augustine Chung
    James English
    Elizabeth R. Volkmann
    Current Treatment Options in Rheumatology, 2019, 5 : 127 - 146
12345